Abstract
A new synthesis of the hexasaccharide MBr1 antigen (gloho-H) is reported. A revised construction with improved efficiency was necessary because an anti-cancer vaccine containing this antigen is entering phase II and phase III clinical trials for prostate cancer. The key feature of this second generation synthesis is the preparation of globo-H as its n-pentenyl glycoside. This group serves as an anomeric protecting group and as a linker for bioconjugation to carrier protein. The resultant synthesis allows for the production of suitable quantities of globo-H for clinical trials.
Original language | English (US) |
---|---|
Pages (from-to) | 1366-1375 |
Number of pages | 10 |
Journal | Chemistry - A European Journal |
Volume | 6 |
Issue number | 8 |
DOIs | |
State | Published - Apr 14 2000 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Catalysis
- Organic Chemistry
Keywords
- Antigens
- Carbohydrates
- Glycoconjugates
- Glycosides
- Immunology